Join Biologics at inSPire2026! (Formerly the NASP Annual Meeting & Expo)

September 22-25, 2026 | Booth #303

 

Picture of the harbor in london

Biologics by McKesson is proud to participate in inSPire2026, the new name for the National Association of Specialty Pharmacy’s (NASP) premier annual conference and expo. As a Topaz Sponsor, we’re excited to join specialty pharmacy leaders and healthcare stakeholders dedicated to advancing patient access and care for complex therapies.

As specialty pharmacy continues to evolve, Biologics remains focused on helping patients access and stay on therapy through personalized clinical support, operational excellence and collaborative care models across oncology, rare disease and cell and gene therapies. We look forward to connecting with peers and partners who share our commitment to improving the patient experience and advancing specialty pharmacy.

Visit Biologics at Booth #303

Connect with our team to explore:

  • Oncology, rare disease and cell & gene therapy support solutions
  • Patient-centered specialty pharmacy care models
  • Clinical innovation and therapy-specific patient support programs
  • Strategies for managing complex and limited-distribution therapies
  • Support solutions for providers, health systems and treatment centers
  • Building collaborative partnerships across the specialty pharmacy ecosystem

Whether you’re exploring new opportunities, sharing insights or building partnerships, we look forward to connecting and discussing what’s next for specialty pharmacy.

Hear from our experts at inSPire2026

How Specialty Pharmacy Is Integrating into CGT Care Models

Tuesday, September 22, 2026
10:10 a.m. – 11:00 a.m. ET

Cell and gene therapies are transforming treatment expectations across multiple disease states, but their successful implementation requires coordination across specialty pharmacies, health systems, treatment centers, providers, manufacturers and payers.

Join this educational panel to explore how specialty pharmacy is integrating into cell and gene therapy care models. Attendees will gain practical insights into operational readiness, cross-functional collaboration, patient engagement strategies and outcomes measurement across the CGT journey. The session will also examine common barriers to implementation and approaches specialty pharmacy teams can use to support access, continuity of care and long-term patient follow-up. CE credits are offered for pharmacists.

Stephanie Patten HeadshotModerator

Stephanie Patten
Vice President, Rare Disease and Advanced Therapies
Biologics by McKesson








Panelists

Nick Calla
Senior Vice President, Industry Relations
Orsini

Joshua Weber
Senior Director & ACPO – Ambulatory, Community & Specialty Pharmacy Services
St. Luke’s Health System

Let's connect at inSPire2026!

Ela Lourido Headshot

Ela Lourido

VP/GM, Specialty Pharmacy Solutions

Portrait of Ryan Hampton, Vice President of Industry Relations and Implementation at Biologics by McKesson.

Ryan Hampton

VP, Industry Relations and Implementation

Stephanie Patten Headshot

Stephanie Patten

VP, Rare Disease and Advanced Therapies

Ben Matherne Headshot

Ben Matherne

VP, Business Insights and Special Projects

Portrait of Ann Fritsche, Managing Lead Counsel at Biologics by McKesson.

Ann Fritsche

Sr. Counsel

Charles Shaw, Biologics Sr. Manager, Strategic Accounts

Charles Shaw

Director, Client Relationship & Clinical Insights

Daniel Weaver Headshot

Daniel Weaver

Director, Clinical Science Liaison

]